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INTRODUCTION:  Type  1  Neuroﬁbromatosis  (NF1)  is  one  of  the  most  common  autosomal  dominantly
inherited  multisystem  disorders.  It is  associated  with  an  increased  risk  of  developing  neurologic  and
gastrointestinal  (GI) malignant  neoplasms.  The  incidence  of GI  involvement  is  reported  in 10–25%  of
patients.  Less  than  5% of  NF1 patients  with  GI neoplasms  manifest  symptoms.  The  presence  of synchronic
gastrointestinal  stromal  and  neuroendocrine  tumors  is  rare  in  these  patients.
PRESENTATION  OF  CASES:  The  ﬁrst case  is  a 37 year-old  male  patient  with  a history  of  abdominal  pain  for
a  few  months.  Imaging  study  showed  a  periampullary  mass  and  a solid  lesion  at  the  third  duodenal  por-
tion.  He  was submitted  to a pancreatoduodenectomy  and  histological  anaylisis  showed  two  low-grade
neuroendocrine  tumors  and  a gastrointestinal  stromal  tumor.  The  second  case  is a 47  year-old  female
patient  with a routine  computed  tomography  scan  showing  a duodenal  and  a  jejunal  lesion.  Duodenopan-
createctomy  was  performed  and  histological  analysis  showed  a  neuroendocrine  adenocarcinoma  of  the
duodenum and  two  jejunal  lesions  compatible  with  GI tumors.
DISCUSSION:  GI  symptoms  such  as  jaundice,  pain  and bleeding  in  NF1 patients  should  prompt  urgent
admission  Occasionally,  associated  gastrointestinal  tumors  may  be incidentally  found  in asymptomatic
NF1  patients.  The  presence  of  a  periampullary  or  duodenal  neoplasia  such  as neuroendocrine  tumors
should be  evaluated.
CONCLUSION:  Although  rare,  the synchronic  presentation  of  gastrointestinal  tumors  in  patients  with
NF1  should  be ruled  out  since  it can  lead  to higher  morbidity  and  mortality  rates.  Single-stage  surgical
management  is feasable  and  yields  satisfactory  results.
© 2016  The  Authors.  Published  by Elsevier  Ltd  on  behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Neuroﬁbromatosis type 1 (NF1) is one of the most common
utosomal dominant inherited multisystem disorders affecting 1
f 3500 births. Itı´s main features are dermal neuroﬁbromas and
igmentary abnormalities such as café au lait patches, axillary
reckling and Lisch nodules of the iris. Also, NF1 is also associ-
ted with an increased risk of developing neural neoplasms such
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as malignant peripheral nerve sheath tumors and optic pathway
gliomas. The gastrointestinal (GI) tract is also affected.
The incidence of GI tract involvement is sometimes difﬁcult
to assess in NF1 patients, although reports have indicated the
presence of tumors in 10–25% of patients, and can be divided
into 3 groups: neural intestinal neoplasms (neuroﬁbromas, gan-
glioneuromatosis, gangliocytic paragangliomas), duodenum and
periampullary neuroendocrine tumors, and gastrointestinal stro-
mal  tumors (GIST) [1–5].
GIST are the most common tumors of mesenchymal origin in the
GI tract. NF1 has been associated with the presence of multiple GIST
throughout the GI tract, most commonly in the small bowel and
stomach. Approximately 60% of patients develop multiple tumors
or multiple tumor sites. GIST alone have been reported in 5–25%
of NF1 patients. The largest series indicates a 7% incidence of GIST
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. This coronal CT image of patient 1 nicely reveals the large periampullary mass
(large arrow), the contrast-enhanced duodenal GIST (small arrow) and a dilated
gallbladder.
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6]. Less than 5% of NF1 patients with GI neoplasms have presented
ith symptoms [5].
Neuroendocrine tumors (NET) may  be either functioning or non-
unctioning, depending on their hormonal activity. Periampullary
umors have also been recognized in patients with NF1[7]. NF1
ssociation with duodenal neuroendocrine tumors, particularly
omatostatin-producing endocrine tumors, although unusual, has
ecently become more widely recognized as a distinct neuroen-
ocrine syndrome [8].
We  present two cases of patients with NF1 that developed neu-
oendocrine tumors of the ampulla of Vater and small bowel GIST,
imultaneously.
. Presentation of cases
First case is a 37-year old male patient presenting to the emer-
ency department in March 2010 complaining of acute right-sided
pper abdominal pain, fever, jaundice, pale-colored stool and dark
rine for four days. He had a history of NF1. His physical exam
howed cutaneous neuroﬁbromas, café au lait maculae and upper
ight side tenderness, with no signs of peritonitis. Laboratory assay
howed direct hyperbilirubinemia, elevated alkaline phosphatase
evels and anemia. No other signiﬁcant abnormalities were noted
n urine and blood tests.
Initial abdominal ultrasound evaluation demonstrated dilation
f intra and extrahepatic bile ducts. Abdominal computerized
omography (CT) and Magnetic Resonance Cholangiopancreatog-
aphy (MRCP) revealed an abrupt narrowing of the distal part of the
ain bile duct, a distended gallbladder, a periampullary mass and a
olid lesion at the third duodenal portion, both contrast-enhanced
Fig. 1). The patient underwent an oesophagogastroduodenoscopy
OGD) (Fig. 2) revealing a partially obstructing and inﬁltrative duo-
enal lesion and an irregular mass at the ampulla of Vater. Biopsy
f the mass showed neuroendocrine cells at the duodenal lamina
ropria with positive chromogranin immunohistochemical stain.
The patient was explored by laparotomy. Intraoperative ﬁndings
evealed a palpable lesion at the duodenum and a one-centimeter
esion at the anti-mesenteric aspect of the jejunum, 80 cm distally
o the Treitz ligament. We  performed pancreaticoduodenectomy,
esection of the jejunal lesion, and Roux-en-Y reconstruction.
athology ﬁndings of the lesions were consistent with two low
rade periampullary neuroendocrine tumors, one of 2.6 cm and
nother of 2.3 cm,  and a 0.9 cm GIST of the jejunal segment (Fig. 3).
The patient had an uneventful recovery. Last follow-up three
ears postoperative he was doing well with no evidence of disease
nd was satisﬁed with the outcome.Second case is a 45-year old female previously diagnosed with
F1 and grade 2 fusocellular sarcoma of the thoracic wall admitted
o our reference service in January 2007 for post-operative follow-
p. She was asymptomatic at the time.
Fig. 2. The OGD for patient 1 shows a bulging mass at the periampullary region.
ig. 3. Ampulla and jejunal well-differentiated neuroendocrine tumor.Proeminente acinar growth patern are seen in this example, in jejunal ressection (a). Somatostatin
taining in Immunohistochemistry (b). CD117/c-Kit expression in GIST, with cytoplasmic and membranous labeling (c). (Hematoxilin and eosin, original magniﬁcation x 50
a],  immunohistochemistry, ×100 [b, c]).
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×ig. 4. OGD view of a polypoid intraluminal lesion of 1.5 cm at the second duodenal
ortion of Patient 2.
Routine follow-up abdominal CT showed a polypoid intralu-
inal lesion of 1.5 cm at the second duodenal portion, and a
.0 cm jejunal nodule, both exposing contrast enhancement. An
GD (Fig. 4) was performed and biopsy of the ﬁrst lesion revealed a
ell − differentiated neuroendocrine tumor of the ampulla of Vater,
ositive for somatostatin. Further evaluation by endoscopic ultra-
ound revealed a 1.5 × 1.0-cm hypoechoic ampullary mass conﬁned
o the mucosa and submucosa.
Pylorus-preserving pancreaticoduodenectomy and resection of
he jejunal lesion (Fig. 5) was performed. Pathology ﬁndings were
ell-differentiated neuroendocrine adenocarcinoma at the level of
he papilla, and two jejunal lesions of 2.5 cm and 0.6 cm,  positive
or CD-117, S-100 protein and smooth muscle actin, consistent with
IST (Fig. 6).
The patient had an uneventful postoperative recovery. Last
ollow-up eight years postoperative she was doing well with no
vidence of disease. She exposed no concerns about the course of
reatment and was pleased with the outcome.
. DiscussionPatients with NF1 are predisposed to both benign and malignant
umors of neurogenic and nonneurogenic origin. Several pathways
re thought to be involved in the development of tumors associ-
ted with NF1. The protein associated with NF1, neuroﬁbromin, is
ig. 6. Duodenal well-differentiated neuroendocrine tumor. This example shows a proem
b).Gastrointestinal stromal tumor cells highlited by CD117/c-KIT stain(c) (Hematoxilin an
200  [c]).Fig. 5. Pedunculated GIST of the jejunum of Patient 2.
involved in the downregulation of the rat sarcoma viral oncogene
homologue (RAS)– mitogen activated protein kinase (MAPK) path-
way and NF1 belongs to the group of RAS–MAPK disorders that
include Noonan, cardio fasciocutaneous, Costello, LEOPARD, and
NF1-like syndrome [9].
GIST are the most common mesenchymal tumors of the GI tract.
They are strongly associated with NF1 and detected in approxi-
mately 7% of the patients. Lifetime risk for patients with NF1 might
be as high as 6% [6]. A review of 167 duodenal GIST from the AFIP
found that 6% were associated with NF1 and, although usually clin-
ically indolent, severe GI bleeding was  a distinctive complication of
this group [6,8]. The clinicopathological characteristics of GIST in
patients with NF1 are different from the characteristics of sporadic
GIST. NF1 GIST are most often small, multiple, and most commonly
distributed in the small bowel. Histologically, the tumors usually
have low mitotic rates. About 22–31% of GISTs in NF1 patients are
found in the duodenum, and approximately 60% of patients harbor
tumors at multiple sites [10]. We  found two  GIST in the proximal
jejunum in our second patient.
Miettinen et al. showed that, in 45 patients who  had NF1 and
GIST, none of the 16 tumors from 15 patients had a KIT mutation
in exon 9, 11, 13, or 17 or a PDGFRA mutation in exon 12 or 18 as
is typical in sporadic GIST. These data clearly indicate that GIST in
NF1 patients have a different pathogenesis than sporadic GIST [6].
The molecular event underlying GIST development in this patient
group may  be a somatic inactivation such as LOH of the wild-type
NF1 allele leading to inactivation of neuroﬁbromin and subsequent
activation of the MAP-kinase pathway [11,12].
inent nest growth pattern (a). A chromogranin stain highlight the neoplastic cell
d eosin, original magniﬁcation ×100 [a], and immunohistochemistry,×100 [b] and
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NET represent a group of neoplasms arising from neuroen-
ocrine cells of the diffuse endocrine system. Most NET are
poradic. However, some NETs, may  occur as part of familial
inherited) syndromes, such as the multiple endocrine neoplasia
 (MEN-1) syndrome, von Hippel Lindau (VHL) syndrome, neu-
oﬁbromatosis, and tuberous sclerosis (TSC). NET of the ampulla
f Vater comprise a broad spectrum of morphologically and
iologically diverse tumors, such as various subtypes of well-
ifferentiated endocrine tumors, well-differentiated endocrine
arcinomas, and poorly differentiated endocrine carcinomas.
Periampullary NET were ﬁrst described in association with NF1
n 1982 by Cantor et al. [13]. In 1989 Klein et al. identiﬁed 37 cases
f NF1 patients with periampullary neoplasms reported in the lit-
rature and noted that 54% were found in the ampulla, 38% in the
uodenum. Histologically, most tumors were NET (41%) [7]. In a
eview of the literature Relles et al. found 76 cases of periampullary
umors in NF1 patients. Most patients were symptomatic (92%). In
his review, 47% of periampullary tumors were neuroendocrine in
rigin [5]. Comparing duodenal somatostatinomas of patients with
F1 (27 patients) and non-NF1 patients (29 patients), Capelli et al.
howed that the non-NF1 patients were less likely to have tumors
ith multiple hormonal production (4.7% vs. 16%) [8].
Corresponding to their location, NET of the ampulla of Vater
ause jaundice in approximately two-thirds of patients. If jaundice
r abdominal pain occurs in patients with NF1 then the possibility
f a NET should be considered. Approximately 26% of all patients
ith NET reported in the literature had NF1 [14].
The presence of synchronous malignant GI tumors in NF1
atients (periampullary NET and small bowel GIST) is rarely
eported in the literature [2,15]. Sometimes during resection of
he periampullary NET, incidental small bowel GIST may  occasion-
lly be found. In patient 1, we found two periampullary NETs and
n small bowel subcentimetric GIST. In patient 2, two  jejunal GIST
ere found.
. Conclusion
GI symptoms such as jaundice, pain and bleeding in NF1 patients
re causes of emergency department admissions. Occasionally,
ssociated GI tumors are incidentally found in asymptomatic NF1
atients. A thorough evaluation to rule out the presence of peri-
mpullary or duodenal neoplasia must be performed. Surgical
ntervention is the deﬁnitive treatment in both situations. Dur-
ng laparotomy careful inspection and palpation of the small
owel should be done. Incidental ﬁnding of small bowel GIST
uring pancreaticoduodenal resection in NF1 patients has been
eported, either isolated or as multiple lesions. Meticulous inves-
igation associated with a careful operative technique could lead
o early diagnosis and treatment of these patients with satisfactory
esults.
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